Comparative Effectiveness of Biologic Disease-modifying Antirheumatic Drugs and Small Molecular Inhibitors in Patients With Moderate to Severe RA: Prospective Observational Study
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Baricitinib (Primary) ; Etanercept (Primary) ; Tocilizumab (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 01 Jul 2020 New trial record